Addition of DLBS1033 to Standard Therapy for Acute Ischemic Stroke Patients
Phase of Trial: Phase II/III
Latest Information Update: 09 Jul 2019
Price : $35 *
At a glance
- Drugs Lumbricus rubellus (Primary) ; Aspirin; Simvastatin; Vitamin B complex
- Indications Stroke
- Focus Therapeutic Use
- Acronyms ADDLIST
- Sponsors Dexa Medica
- 24 Jan 2019 Planned End Date changed from 1 Feb 2019 to 1 Feb 2021.
- 24 Jan 2019 Planned primary completion date changed from 1 Nov 2018 to 1 Nov 2020.
- 31 Aug 2018 Biomarkers information updated